lipoprotein modulator (MedImmune)

N/A

Report date: 2025/03/20 16:08:09
NME

Base Information

Drug Namelipoprotein modulator (MedImmune)
Drug Alias Namelipoprotein modulator (Shionogi)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionLipoprotein modulators
TargetsUpdating
Therapy Area/IndicationsAcute Coronary Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesJapan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesShionogi & Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesMedimmune Llc
Inactive CompaniesShionogi & Co Ltd
Active IndicationsAcute Coronary Syndrome
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A